Red blood cell fatty acid patterns and acute coronary syndrome

Gregory C Shearer1, James V Pottala, John A Spertus

  • 1Sanford Research/USD, Cardiovascular Health Research Center, Sioux Falls, SD, USA.

Plos One
|May 8, 2009
PubMed

Insights

Red blood cell fatty acid (RBC-FA) profiles significantly improve acute coronary syndrome (ACS) risk prediction compared to standard factors alone. Combining RBC-FA profiles with standard risk factors offers the best discrimination for ACS cases.

Area of Science:

  • Cardiovascular Disease Research
  • Lipidomics
  • Biomarker Discovery

Background:

  • Coronary heart disease (CHD) risk assessment traditionally relies on standard risk factors.
  • Novel lipidomic approaches, specifically red blood cell fatty acid (RBC-FA) profiles, are being explored for enhanced risk stratification.
  • The diagnostic and prognostic utility of RBC-FA profiles in acute coronary syndrome (ACS) requires further elucidation.

Purpose of the Study:

  • To evaluate the discriminatory power of RBC-FA profiles for acute coronary syndrome (ACS) cases versus controls.
  • To compare the performance of RBC-FA profiles against established standard risk factors (SRF) in ACS discrimination.
  • To assess the added value of incorporating RBC-FA profiles into existing risk prediction models.

Main Methods:

  • Red blood cell fatty acid (RBC-FA) profiles were analyzed in 668 ACS cases and 680 matched controls.
  • Multivariable logistic regression models were constructed using FA profiles (FA) and standard risk factors (SRF) on a derivation set and validated.
  • Model performance was assessed using receiver operating characteristic (ROC) curves (c-statistics), misclassification rates, and calibration.

Main Results:

  • RBC-FA profiles demonstrated superior discrimination of ACS cases compared to SRF (c-statistic 0.85 vs. 0.77, p=0.003).
  • The addition of RBC-FA profiles significantly improved the combined model's discrimination (c-statistic 0.88 vs. 0.77, p<0.0001).
  • The combined model achieved the lowest misclassification rate (20%) and acceptable calibration.

Conclusions:

  • RBC-FA profiles significantly enhance the discrimination of ACS cases.
  • Combining RBC-FA profiles with standard risk factors provides a more robust risk prediction model.
  • Further research is warranted to explore the clinical utility of FA patterns in cardiovascular risk prediction.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Inflammation01:38

Inflammation

Overview